Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

• Conditions: Haemodialysis

• Registration Number: NCT02902848
• Lead Sponsor: University Hospital, Brest

Brief Summary

The purpose of this study is to evaluate the INR value of hemodialyzed patient coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to a portable monitor. The values obtained at the point of care will be compared to the standard biological assessment.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03
• Status Verified: 2016-09
• Study First Submitted: 2016-09-08
• Study First Submitted QC: 2016-09-13
• Last Update Submitted: 2016-09-13
• Study First Posted: 2016-09-16
• Last Update Posted: 2016-09-16
• Primary Completion: 2017-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Age > 18
• Haemodialyzed patient whose INR needs to be monitored
• Patient not objecting to participate in the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
correlation ratio between point-of-care PT/INR value and standard laboratory assessement	5 months

Trial Locations

Locations (1)

CHU Brest; 🇫🇷 Brest, France